3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Hodgkin Disease
5
Lymphoma
4
Recurrence
3
Lymphoma, T-Cell
3
Lymphoma, Follicular
3
Uveal Melanoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Glioblastoma
2
Burkitt Lymphoma
2
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Opsoclonus-Myoclonus Syndrome
1
Oligodendroglioma
1
Neuromyelitis Optica
1
Neoplasms
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Cyclophosphamide
12
fludarabine phosphate
7
fludarabine
7
venetoclax
6
blinatumomab
6
Cytarabine
5
Lenalidomide
4
Dexamethasone
4
Blood Specimen Collection
4
Azacitidine
4
obinutuzumab
3
Rituximab
3
Radiotherapy
3
Melphalan
3
Immunotherapy, Adoptive
3
pembrolizumab
2
daratumumab
2
Neoadjuvant Therapy
2
Idarubicin
2
Chemotherapy, Adjuvant
2
Capecitabine
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sacituzumab govitecan
1
sabatolimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Carmustine
×
1 year
×
Clear all
No trials found.